Norges Bank’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9M | Buy |
+468,329
| New | +$48.9M | 0.01% | 960 |
|
|
2025
Q1 | – | Sell |
-403,026
| Closed | -$34.1M | – | 172 |
|
|
2024
Q4 | $34.1M | Buy |
+403,026
| New | +$34.1M | ﹤0.01% | 1109 |
|
|
2024
Q3 | – | Sell |
-404,217
| Closed | -$32.5M | – | 174 |
|
|
2024
Q2 | $32.5M | Buy |
404,217
+18,666
| +5% | +$1.5M | ﹤0.01% | 1081 |
|
|
2024
Q1 | $30.8M | Buy |
385,551
+190,428
| +98% | +$15.2M | ﹤0.01% | 1138 |
|
|
2023
Q4 | $15.5M | Sell |
195,123
-15,099
| -7% | -$1.2M | ﹤0.01% | 1341 |
|
|
2023
Q3 | $14.7M | Hold |
210,222
| – | – | ﹤0.01% | 1334 |
|
|
2023
Q2 | $15.1M | Hold |
210,222
| – | – | ﹤0.01% | 1379 |
|
|
2023
Q1 | $13M | Sell |
210,222
-46,175
| -18% | -$2.85M | ﹤0.01% | 1470 |
|
|
2022
Q4 | $19.8M | Hold |
256,397
| – | – | ﹤0.01% | 1275 |
|
|
2022
Q3 | $11.4M | Buy |
256,397
+23,351
| +10% | +$1.04M | ﹤0.01% | 1480 |
|
|
2022
Q2 | $8.93M | Buy |
233,046
+55,766
| +31% | +$2.14M | ﹤0.01% | 1606 |
|
|
2022
Q1 | $7.34M | Sell |
177,280
-15,049
| -8% | -$623K | ﹤0.01% | 1789 |
|
|
2021
Q4 | $7.27M | Hold |
192,329
| – | – | ﹤0.01% | 1841 |
|
|
2021
Q3 | $6.34M | Buy |
192,329
+130,106
| +209% | +$4.29M | ﹤0.01% | 1886 |
|
|
2021
Q2 | $4.2M | Sell |
62,223
-145,699
| -70% | -$9.83M | ﹤0.01% | 1930 |
|
|
2021
Q1 | $11.8M | Sell |
207,922
-66,987
| -24% | -$3.79M | ﹤0.01% | 1745 |
|
|
2020
Q4 | $22.4M | Sell |
274,909
-8,946
| -3% | -$729K | 0.01% | 1497 |
|
|
2020
Q3 | $20.2M | Sell |
283,855
-122,343
| -30% | -$8.72M | 0.01% | 1414 |
|
|
2020
Q2 | $33.4M | Buy |
406,198
+97,806
| +32% | +$8.05M | 0.01% | 1116 |
|
|
2020
Q1 | $18.1M | Buy |
+308,392
| New | +$18.1M | 0.01% | 1312 |
|